Home 2023

Lonza

Biopharma Taps Bioprocessing 4.0, Benefits Start Flowing
Bioprocessing

Biopharma Taps Bioprocessing 4.0, Benefits Start Flowing

Kathy Vuksanaj -
0
Cell Culture Media System
New Products

Cell Culture Media System

Christina Jackson -
0
Lonza Enters Bispecific Antibody Collaboration with ABL Bio
Bioprocessing

Lonza Enters Bispecific Antibody Collaboration with ABL Bio

John Sterling -
0
Biomanufacturing Facility Upgrades at Catalent, Recipharm, and Lonza
News

Biomanufacturing Facility Upgrades at Catalent, Recipharm, and Lonza

John Sterling -
0
Lonza Collaborates with Cristal Therapeutics and McSAF to Expand Bioconjugates Offering
Drug Discovery

Lonza Collaborates with Cristal Therapeutics and McSAF to Expand Bioconjugates Offering

John Sterling -
0
Antibody Drug Conjugates Form Basis of Lonza and AbTis Collaboration
Bioprocessing

Antibody Drug Conjugates Form Basis of Lonza and AbTis Collaboration

John Sterling -
0
Lonza Expands Multipurpose Suite
Bioprocessing

Lonza Expands Multipurpose Suite

John Sterling -
0
Lonza and the Israel Biotech Fund Ink Development and Manufacturing Deal
Bioprocessing

Lonza and the Israel Biotech Fund Ink Development and Manufacturing Deal

John Sterling -
0
Lonza and Integral Molecular Offer to Enhance Early De-Risking of Clients’ Biotherapeutics
Bioprocessing

Lonza and Integral Molecular Offer to Enhance Early De-Risking of Clients’ Biotherapeutics

John Sterling -
0
Lonza Will Manufacture Asher Bio’s Cis-targeted IL-2 Fusion Protein
Bioprocessing

Lonza Will Manufacture Asher Bio’s Cis-targeted IL-2 Fusion Protein

John Sterling -
0
123...14Page 1 of 14
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.